143 related articles for article (PubMed ID: 34648466)
21. How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Bongers MER; Karhade AV; Setola E; Gambarotti M; Groot OQ; Erdoğan KE; Picci P; Donati DM; Schwab JH; Palmerini E
Clin Orthop Relat Res; 2020 Oct; 478(10):2300-2308. PubMed ID: 32433107
[TBL] [Abstract][Full Text] [Related]
22. [Dedifferentiated chondrosarcoma. A study of 13 clinical cases and review of the literature].
Anract P; Tomeno B; Forest M
Rev Chir Orthop Reparatrice Appar Mot; 1994; 80(8):669-80. PubMed ID: 7638395
[TBL] [Abstract][Full Text] [Related]
23. Association of extent of local tumor invasion and survival in patients with malignant primary osseous spinal neoplasms from the surveillance, epidemiology, and end results (SEER) database.
Mukherjee D; Chaichana KL; Adogwa O; Gokaslan Z; Aaronson O; Cheng JS; McGirt MJ
World Neurosurg; 2011 Dec; 76(6):580-5. PubMed ID: 22251507
[TBL] [Abstract][Full Text] [Related]
24. Dedifferentiated Chondrosarcoma Demonstrating Osteosarcomatous Differentiation.
Dhinsa BS; DeLisa M; Pollock R; Flanagan AM; Whelan J; Gregory J
Oncol Res Treat; 2018; 41(7-8):456-460. PubMed ID: 29902785
[TBL] [Abstract][Full Text] [Related]
25. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
[TBL] [Abstract][Full Text] [Related]
26. Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.
Bongers MER; Thio QCBS; Karhade AV; Stor ML; Raskin KA; Lozano Calderon SA; DeLaney TF; Ferrone ML; Schwab JH
Clin Orthop Relat Res; 2019 Oct; 477(10):2296-2303. PubMed ID: 31107338
[TBL] [Abstract][Full Text] [Related]
27. What Factors Are Associated with Treatment Outcomes of Japanese Patients with Clear Cell Chondrosarcoma?
Nakayama R; Hayakawa K; Kobayashi E; Endo M; Asano N; Yonemoto T; Kawashima H; Hamada K; Watanabe I; Futani H; Goto T; Nishida Y; Ozaki T
Clin Orthop Relat Res; 2020 Nov; 478(11):2537-2547. PubMed ID: 32297725
[TBL] [Abstract][Full Text] [Related]
28. Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
Thio QCBS; Karhade AV; Ogink PT; Raskin KA; De Amorim Bernstein K; Lozano Calderon SA; Schwab JH
Clin Orthop Relat Res; 2018 Oct; 476(10):2040-2048. PubMed ID: 30179954
[TBL] [Abstract][Full Text] [Related]
29. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database.
Giuffrida AY; Burgueno JE; Koniaris LG; Gutierrez JC; Duncan R; Scully SP
J Bone Joint Surg Am; 2009 May; 91(5):1063-72. PubMed ID: 19411454
[TBL] [Abstract][Full Text] [Related]
30. C-reactive protein: An independent predictor for dedifferentiated chondrosarcoma.
Nemecek E; Funovics PT; Hobusch GM; Lang S; Willegger M; Sevelda F; Brodowicz T; Stihsen C; Windhager R; Panotopoulos J
J Orthop Res; 2018 Oct; 36(10):2797-2801. PubMed ID: 29701260
[TBL] [Abstract][Full Text] [Related]
31. Pelvic chondrosarcomas: surgical treatment options.
Deloin X; Dumaine V; Biau D; Karoubi M; Babinet A; Tomeno B; Anract P
Orthop Traumatol Surg Res; 2009 Oct; 95(6):393-401. PubMed ID: 19801212
[TBL] [Abstract][Full Text] [Related]
32. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group.
Grimer RJ; Gosheger G; Taminiau A; Biau D; Matejovsky Z; Kollender Y; San-Julian M; Gherlinzoni F; Ferrari C
Eur J Cancer; 2007 Sep; 43(14):2060-5. PubMed ID: 17720491
[TBL] [Abstract][Full Text] [Related]
33. Effect of surgery and radiotherapy on overall survival in patients with chondrosarcoma: A SEER-based study.
Wang M; Song Y; Liu S; Sun W
J Orthop Surg (Hong Kong); 2022; 30(1):10225536221086319. PubMed ID: 35349776
[TBL] [Abstract][Full Text] [Related]
34. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
35. A Systematic Review of Adjuvant Chemotherapy in Localized Dedifferentiated Chondrosarcoma.
Tsukamoto S; Mavrogenis AF; Nitta Y; Righi A; Masunaga T; Honoki K; Fujii H; Kido A; Tanaka Y; Tanaka Y; Errani C
Curr Oncol; 2024 Jan; 31(1):566-578. PubMed ID: 38275833
[TBL] [Abstract][Full Text] [Related]
36. Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?
Song K; Shi X; Wang H; Zou F; Lu F; Ma X; Xia X; Jiang J
Clin Orthop Relat Res; 2018 May; 476(5):987-996. PubMed ID: 29470233
[TBL] [Abstract][Full Text] [Related]
37. Extraskeletal myxoid chondrosarcoma: Clinical features and overall survival.
Brown JM; Rakoczy K; Pretell-Mazzini J
Cancer Treat Res Commun; 2022; 31():100530. PubMed ID: 35144048
[TBL] [Abstract][Full Text] [Related]
38. Advanced chondrosarcomas: role of chemotherapy and survival.
Italiano A; Mir O; Cioffi A; Palmerini E; Piperno-Neumann S; Perrin C; Chaigneau L; Penel N; Duffaud F; Kurtz JE; Collard O; Bertucci F; Bompas E; Le Cesne A; Maki RG; Ray Coquard I; Blay JY
Ann Oncol; 2013 Nov; 24(11):2916-22. PubMed ID: 24099780
[TBL] [Abstract][Full Text] [Related]
39. Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Hompland I; Ferrari S; Bielack S; Palmerini E; Hall KS; Picci P; Hecker-Nolting S; Donati DM; Blattmann C; Bjerkehagen B; Staals E; Kager L; Gambarotti M; Kühne T; Eriksson M; Ferraresi V; Kevric M; Biagini R; Baumhoer D; Brosjø O; Comandone A; Schwarz R; Bertulli R; Kessler T; Hansson L; Apice G; Heydrich BN; Setola E; Flörcken A; Ruggieri P; Krasniqi F; Hofmann-Wackersreuther G; Casali P; Reichardt P; Smeland S
Eur J Cancer; 2021 Jul; 151():150-158. PubMed ID: 33990016
[TBL] [Abstract][Full Text] [Related]
40. Predictors of the survival of patients with chondrosarcoma of bone and metastatic disease at diagnosis.
Wang Z; Chen G; Chen X; Huang X; Liu M; Pan W; Yan X; Lin N; Ye Z
J Cancer; 2019; 10(11):2457-2463. PubMed ID: 31258751
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]